"Diffusible-PEG-Lipid Stabilized Plasmid Lipid Particles"

Many viral and non-viral gene transfer systems suffer from common pharmacological issues that limit their utility in a systemic context. By application of the liposomal drug delivery paradigm, many of the limitations of the first generation non-viral delivery systems can be overcome. Encapsulation in small, long-circulating particles called stabilized plasmid lipid particles (SPLP) results in enhanced accumulation at disease sites and selective protein expression. This work compares the detergent dialysis method of SPLP manufacture with an alternative method, spontaneous vesicle formation by ethanol dilution. The pharmacology of SPLP, as determined by monitoring lipid label and quantitative real time PCR, is also presented.

[1]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Hashida,et al.  Interaction between DNA–cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid , 2001, Gene Therapy.

[3]  M. Bassik,et al.  DNA vector chemistry: The covalent attachment of signal peptides to plasmid DNA , 1998, Nature Biotechnology.

[4]  P. Cullis,et al.  Stabilized Plasmid–Lipid Particles: Pharmacokinetics and Plasmid Delivery to Distal Tumors following Intravenous Injection , 2000, Journal of drug targeting.

[5]  R. Mannino,et al.  Encapsulation of high molecular weight DNA in large unilamellar phospholipid vesicles , 1979, FEBS letters.

[6]  J. H. Axelrod,et al.  Liposome-encapsulated DNA-mediated gene transfer and synthesis of human factor IX in mice. , 1995, Gene.

[7]  B. de Kruijff,et al.  The polymorphic phase behaviour of phosphatidylethanolamines of natural and synthetic origin. A 31P NMR study. , 1978, Biochimica et biophysica acta.

[8]  O. Danos,et al.  In Vivo Gene Transfer by Intravenous Administration of Stable Cationic Lipid/DNA Complex , 1997, Pharmaceutical Research.

[9]  M. Fornerod,et al.  Nucleocytoplasmic Transport: The Last 200 Nanometers , 1998, Cell.

[10]  O. Stein,et al.  Biological stability of [3H]cholesteryl oleyl ether in cultured fibroblasts and intact rat , 1980, FEBS letters.

[11]  G. Acsadi,et al.  Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. , 1992, Human molecular genetics.

[12]  D. Russell,et al.  Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. , 1985, Annual review of cell biology.

[13]  Leaf Huang,et al.  Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer (*) , 1996, The Journal of Biological Chemistry.

[14]  Y. Kaneda,et al.  Fusigenic viral liposome for gene therapy in cardiovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Cullis,et al.  Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties. , 1999, Biochimica et biophysica acta.

[16]  P. Cullis,et al.  Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. , 2001, Biophysical journal.

[17]  L. Mahan,et al.  Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Liggitt,et al.  Cationic Liposome-mediated Intravenous Gene Delivery (*) , 1995, The Journal of Biological Chemistry.

[19]  T. Chen,et al.  Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids. , 2003, Biochimica et biophysica acta.

[20]  D Needham,et al.  Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. , 1993, Cancer research.

[21]  K. Mislick,et al.  Evidence for the role of proteoglycans in cation-mediated gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Duda,et al.  Entrapment of high-molecular-mass DNA molecules in liposomes for the genetic transformation of animal cells. , 1989, The Biochemical journal.

[23]  R. Debs,et al.  Proteoglycans Mediate Cationic Liposome-DNA Complex-based Gene Delivery in Vitro and in Vivo * , 1998, The Journal of Biological Chemistry.

[24]  D. Hadjiminas,et al.  Construction of transferrin-coated liposomes for in vivo transport of exogenous DNA to bone marrow erythroblasts in rabbits. , 1986, Experimental cell research.

[25]  C. Nicolau,et al.  Intracellular fate of liposome-encapsulated DNA in mouse liver. Analysis using electron microscope autoradiography and subcellular fractionation. , 1985, Biochimica et biophysica acta.

[26]  D. Liggitt,et al.  Systemic gene expression after intravenous DNA delivery into adult mice. , 1993, Science.

[27]  Xiang Gao,et al.  Cationic liposome-mediated gene transfer. , 1995, Gene therapy.

[28]  P. Luisi,et al.  Entrapment of nucleic acids in liposomes. , 1997, Biochimica et biophysica acta.

[29]  C. Nicolau,et al.  Expression of a beta-lactamase activity in Mycoplasma capricolum transfected with the liposome-encapsulated E.coli pBR 322 plasmid. , 1982, Biochemical and biophysical research communications.

[30]  P. Cullis,et al.  Modulation of membrane fusion by asymmetric transbilayer distributions of amino lipids. , 1994, Biochemistry.

[31]  S W Hui,et al.  The role of helper lipids in cationic liposome-mediated gene transfer. , 1996, Biophysical journal.

[32]  H. Lodish,et al.  Intracellular site of asialoglycoprotein receptor-ligand uncoupling: Double-label immunoelectron microscopy during receptor-mediated endocytosis , 1983, Cell.

[33]  T. P. Stewart,et al.  Membrane fusion through point defects in bilayers. , 1981, Science.

[34]  W. Gilbert,et al.  Basic protein enhances the incorporation of DNA into lipid vesicles: model for the formation of primordial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Parker,et al.  Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. , 1995, Human gene therapy.

[36]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Strey,et al.  Improved DNA: liposome complexes for increased systemic delivery and gene expression , 1997, Nature Biotechnology.

[38]  Lipid polymorphism and the functional roles of lipids in biological membranes. , 1979 .

[39]  L. Huang,et al.  pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Philippot,et al.  A new cationic liposome encapsulating genetic material. A potential delivery system for polynucleotides. , 1995, European journal of biochemistry.

[41]  A. Thierry,et al.  Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA , 1997, Gene Therapy.

[42]  R. Hoffman,et al.  Binding and entrapment of high molecular weight DNA by lecithin liposomes , 1978, FEBS letters.

[43]  I. Maclachlan,et al.  Cationic lipid-mediated transfection of cells in culture requires mitotic activity , 1999, Gene Therapy.

[44]  I. Wróbel,et al.  Fusion of cationic liposomes with mammalian cells occurs after endocytosis. , 1995, Biochimica et biophysica acta.

[45]  D. Papahadjopoulos,et al.  Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery , 1997, FEBS letters.

[46]  T. Curiel,et al.  Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells. , 1995, BioTechniques.

[47]  P. Cullis,et al.  Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties , 1999, Gene Therapy.

[48]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[49]  A. Eastman,et al.  Deoxyribonuclease II is a lysosomal barrier to transfection. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  P. Godowski,et al.  Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. , 1996, Journal of Pharmacy and Science.

[51]  L. Palmer,et al.  Stabilized plasmid-lipid particles: construction and characterization , 1999, Gene Therapy.

[52]  M. Ishiura,et al.  Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus). , 1985, Experimental cell research.

[53]  M. Bally,et al.  Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia , 2004, Cancer Chemotherapy and Pharmacology.

[54]  Philippe Soriano,et al.  Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. Gariglio,et al.  Spermidine-condensed DNA and cone-shaped lipids improve delivery and expression of exogenous DNA transfer by liposomes. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[56]  P. Lurquin.  Entrapment of plasmid DNA by liposomes and their interactions with plant protoplasts. , 1979, Nucleic acids research.

[57]  O. Ludkovski,et al.  Stabilized plasmid-lipid particles for systemic gene therapy , 2000, Gene Therapy.

[58]  D. Devine,et al.  The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. , 1991, Journal of immunology.

[59]  D. Marsh,et al.  Effect of acyl chain composition on salt-induced lamellar to inverted hexagonal phase transitions in cardiolipin. , 1989, Biochimica et biophysica acta.

[60]  L. Huang,et al.  In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes , 1997, Gene Therapy.

[61]  L. Huang,et al.  Safety study and characterization of E1A–liposome complex gene-delivery protocol in an ovarian cancer model , 1998, Gene Therapy.

[62]  D Needham,et al.  Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. , 1992, Biochimica et biophysica acta.

[63]  T M Allen,et al.  Large unilamellar liposomes with low uptake into the reticuloendothelial system , 1987, FEBS letters.

[64]  S. Kaplan,et al.  Entrapment of a bacterial plasmid in phospholipid vesicles: potential for gene transfer. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Kumar,et al.  Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. , 1994, The Journal of biological chemistry.

[66]  Philippe Soriano,et al.  In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[67]  F. Maxfield,et al.  Delivery of ligands from sorting endosomes to late endosomes occurs by maturation of sorting endosomes , 1992, The Journal of cell biology.

[68]  M. Bally,et al.  Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. , 1994, Cancer research.

[69]  T Salditt,et al.  An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. , 1998, Science.

[70]  L. Jeffs,et al.  A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA , 2005, Pharmaceutical Research.

[71]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[72]  R. Rand,et al.  The effects of acyl chain length and saturation of diacylglycerols and phosphatidylcholines on membrane monolayer curvature. , 2002, Biophysical journal.

[73]  R. Scheule,et al.  DNA sequences in cationic lipid:pDNA-mediated systemic toxicities. , 2003, Human gene therapy.

[74]  L. Huang,et al.  Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications. , 1992, Biochimica et biophysica acta.

[75]  G Gregoriadis,et al.  Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.

[76]  R. Epand,et al.  Promotion of hexagonal phase formation and lipid mixing by fatty acids with varying degrees of unsaturation. , 1991, Chemistry and physics of lipids.

[77]  H. Farhood,et al.  The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. , 1995, Biochimica et biophysica acta.

[78]  M. Bally,et al.  Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. , 1995, British Journal of Cancer.

[79]  M. Bally,et al.  Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors. , 1990, Cancer research.

[80]  Leaf Huang,et al.  Liposomal gene delivery: A complex package , 1997, Nature Biotechnology.

[81]  I. Maclachlan,et al.  Stabilized plasmid-lipid particles: a systemic gene therapy vector. , 2002, Methods in enzymology.

[82]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[83]  R. Murphy,et al.  Endosome maturation: insights from somatic cell genetics and cell-free analysis. , 1993, Biochemical Society transactions.

[84]  S. Aliño,et al.  In Vivo Delivery of Human α1-Antitrypsin Gene to Mouse Hepatocytes by Liposomes , 1993 .

[85]  M. Schaefer-Ridder,et al.  Liposomes as gene carriers: efficient transformation of mouse L cells by thymidine kinase gene. , 1982, Science.

[86]  L. Huang,et al.  Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. , 1989, Biochemistry.

[87]  I. Maclachlan,et al.  Long-circulating vectors for the systemic delivery of genes. , 2001, Current opinion in molecular therapeutics.

[88]  A T Hoogeveen,et al.  Efficacy of a peptide-based gene delivery system depends on mitotic activity. , 1996, Gene therapy.

[89]  P. Cullis,et al.  On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.

[90]  J. Behr,et al.  A model for non‐viral gene delivery: through syndecan adhesion molecules and powered by actin , 2004, The journal of gene medicine.

[91]  B. de Kruijff,et al.  Synthesis and polymorphic phase behaviour of polyunsaturated phosphatidylcholines and phosphatidylethanolamines. , 1983, Chemistry and physics of lipids.

[92]  P Berg,et al.  Introduction of liposome-encapsulated SV40 DNA into cells. , 1980, The Journal of biological chemistry.

[93]  C. L. Johnson,et al.  Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. , 2000, Human gene therapy.

[94]  J. Behr,et al.  Monomolecular collapse of plasmid DNA into stable virus-like particles. , 1998, Proceedings of the National Academy of Sciences of the United States of America.